| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 777,7 k € | -8.1% | 846,1 k € | +25.7% | 673,3 k € | -23.5% | 879,7 k € | -5.9% | 934,6 k € | +48.1% | 631,1 k € | +1.1% | 624,1 k € | +3.2% | 604,7 k € | +3.4% | 584,8 k € | +5.6% | 553,6 k € | -27.8% | 766,5 k € | |
| EBITDA | 774,4 k € | -8.2% | 843,5 k € | +25.7% | 671,3 k € | -23.5% | 877,0 k € | -5.6% | 929,4 k € | +47.8% | 628,8 k € | +1.2% | 621,6 k € | +3.3% | 601,7 k € | +3.2% | 582,9 k € | +5.7% | 551,4 k € | -27.9% | 764,8 k € | |
| Operating profit | 749,1 k € | -7.2% | 807,0 k € | +24.8% | 646,6 k € | -23.8% | 849,0 k € | -5.9% | 902,5 k € | +45.7% | 619,6 k € | +2.1% | 607,1 k € | +4.3% | 581,8 k € | +3.2% | 563,7 k € | +5.2% | 536,0 k € | -29.0% | 755,1 k € | |
| Profit/loss | 621,6 k € | -3.2% | 642,5 k € | +32.8% | 483,9 k € | -21.1% | 613,2 k € | -2.4% | 628,1 k € | +44.2% | 435,6 k € | +7.9% | 403,7 k € | +5.3% | 383,5 k € | +13.2% | 338,6 k € | +4.6% | 323,9 k € | -27.8% | 448,8 k € | |
| Equity | 5,3 M € | +13.2% | 4,7 M € | +15.8% | 4,1 M € | +12.9% | 3,6 M € | +20.6% | 3,0 M € | +26.7% | 2,4 M € | +22.7% | 1,9 M € | +26.7% | 1,5 M € | +33.9% | 1,1 M € | +42.8% | 791,3 k € | +69.3% | 467,4 k € | |
| Total assets | 5,4 M € | +13.3% | 4,7 M € | +16.2% | 4,1 M € | +10.9% | 3,7 M € | +19.8% | 3,1 M € | +25.9% | 2,4 M € | +24.0% | 2,0 M € | +25.3% | 1,6 M € | +34.4% | 1,2 M € | +41.4% | 826,8 k € | +27.5% | 648,7 k € | |
| Cash | 253,2 k € | -46.1% | 469,7 k € | +218.9% | 147,3 k € | -88.7% | 1,3 M € | -29.8% | 1,9 M € | +29.5% | 1,4 M € | +7.5% | 1,3 M € | +12.1% | 1,2 M € | +26.7% | 939,0 k € | +21.2% | 774,7 k € | +30.2% | 595,1 k € | |
| Debts | 51,4 k € | +19.1% | 43,2 k € | +69.9% | 25,4 k € | -71.4% | 88,7 k € | -4.5% | 92,9 k € | +5.8% | 87,9 k € | +68.5% | 52,1 k € | -10.4% | 58,2 k € | +47.4% | 39,5 k € | +11.3% | 35,5 k € | -80.4% | 180,7 k € | |
Private limited company · Waasmunster · incorporated on 19/06/2015
Private limited company profitable and well capitalised. Cash position declining (-46.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Tania Bril, klinisch bioloog is a Private limited company incorporated in 2015. Its main activity is: Other human health activities. Its registered office is in Waasmunster.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.